Company Profile

The founders of OctreoPharm Sciences

The OctreoPharm Sciences GmbH (OPS) was founded in 2009 by Dr. Hakim Bouterfa and Udo Blaseg, formerly colleagues at Molecular Insight Pharmaceuticals (Europe) GmbH.

OPS is a biopharmaceutical company in the fields of radioactively labeled pharmaceuticals.

The company focuses in particular on the development of new radiopharmaceuticals for neuroendocrine tumors. Its products will intend to improve the lives of patients through timely and accurate detection, effective monitoring of therapeutic response, disease progression and an improved treatment.